Nextcure Stock Technical Analysis
| NXTC Stock | USD 12.86 0.36 2.72% |
As of the 25th of February, NextCure secures the Downside Deviation of 4.14, mean deviation of 4.14, and Risk Adjusted Performance of 0.0774. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NextCure, as well as the relationship between them.
NextCure Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as NextCure, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NextCureNextCure's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.NextCure Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 17.67 | Buy | 2 | Odds |
Most NextCure analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand NextCure stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of NextCure, talking to its executives and customers, or listening to NextCure conference calls.
Will Biotechnology sector continue expanding? Could NextCure diversify its offerings? Factors like these will boost the valuation of NextCure. Anticipated expansion of NextCure directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every NextCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of NextCure is measured differently than its book value, which is the value of NextCure that is recorded on the company's balance sheet. Investors also form their own opinion of NextCure's value that differs from its market value or its book value, called intrinsic value, which is NextCure's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because NextCure's market value can be influenced by many factors that don't directly affect NextCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between NextCure's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NextCure should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, NextCure's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
NextCure 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NextCure's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NextCure.
| 11/27/2025 |
| 02/25/2026 |
If you would invest 0.00 in NextCure on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding NextCure or generate 0.0% return on investment in NextCure over 90 days. NextCure is related to or competes with Q32 Bio, Plus Therapeutics, Boundless Bio, Verrica Pharmaceuticals, AN2 Therapeutics, Jasper Therapeutics, and Intensity Therapeutics. NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines ... More
NextCure Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NextCure's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NextCure upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.14 | |||
| Information Ratio | 0.0731 | |||
| Maximum Drawdown | 43.11 | |||
| Value At Risk | (6.41) | |||
| Potential Upside | 8.77 |
NextCure Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NextCure's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NextCure's standard deviation. In reality, there are many statistical measures that can use NextCure historical prices to predict the future NextCure's volatility.| Risk Adjusted Performance | 0.0774 | |||
| Jensen Alpha | 0.4903 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.1095 | |||
| Treynor Ratio | 0.9234 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NextCure's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NextCure February 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0774 | |||
| Market Risk Adjusted Performance | 0.9334 | |||
| Mean Deviation | 4.14 | |||
| Semi Deviation | 3.83 | |||
| Downside Deviation | 4.14 | |||
| Coefficient Of Variation | 1117.85 | |||
| Standard Deviation | 6.19 | |||
| Variance | 38.34 | |||
| Information Ratio | 0.0731 | |||
| Jensen Alpha | 0.4903 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.1095 | |||
| Treynor Ratio | 0.9234 | |||
| Maximum Drawdown | 43.11 | |||
| Value At Risk | (6.41) | |||
| Potential Upside | 8.77 | |||
| Downside Variance | 17.11 | |||
| Semi Variance | 14.7 | |||
| Expected Short fall | (4.93) | |||
| Skewness | 2.63 | |||
| Kurtosis | 12.64 |
NextCure Backtested Returns
NextCure has Sharpe Ratio of -0.0148, which conveys that the firm had a -0.0148 % return per unit of risk over the last 3 months. NextCure exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NextCure's Risk Adjusted Performance of 0.0774, downside deviation of 4.14, and Mean Deviation of 4.14 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.59, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NextCure's returns are expected to increase less than the market. However, during the bear market, the loss of holding NextCure is expected to be smaller as well. At this point, NextCure has a negative expected return of -0.0637%. Please make sure to verify NextCure's semi variance, as well as the relationship between the daily balance of power and period momentum indicator , to decide if NextCure performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.70 |
Good predictability
NextCure has good predictability. Overlapping area represents the amount of predictability between NextCure time series from 27th of November 2025 to 11th of January 2026 and 11th of January 2026 to 25th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NextCure price movement. The serial correlation of 0.7 indicates that around 70.0% of current NextCure price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.7 | |
| Spearman Rank Test | -0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 1.04 |
NextCure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
NextCure Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for NextCure across different markets.
About NextCure Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of NextCure on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of NextCure based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on NextCure price pattern first instead of the macroeconomic environment surrounding NextCure. By analyzing NextCure's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of NextCure's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to NextCure specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 16.38 | 7.5 | 6.75 | 6.41 | Net Debt To EBITDA | 0.1 | 0.4 | 0.46 | 0.44 |
NextCure February 25, 2026 Technical Indicators
Most technical analysis of NextCure help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NextCure from various momentum indicators to cycle indicators. When you analyze NextCure charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0774 | |||
| Market Risk Adjusted Performance | 0.9334 | |||
| Mean Deviation | 4.14 | |||
| Semi Deviation | 3.83 | |||
| Downside Deviation | 4.14 | |||
| Coefficient Of Variation | 1117.85 | |||
| Standard Deviation | 6.19 | |||
| Variance | 38.34 | |||
| Information Ratio | 0.0731 | |||
| Jensen Alpha | 0.4903 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.1095 | |||
| Treynor Ratio | 0.9234 | |||
| Maximum Drawdown | 43.11 | |||
| Value At Risk | (6.41) | |||
| Potential Upside | 8.77 | |||
| Downside Variance | 17.11 | |||
| Semi Variance | 14.7 | |||
| Expected Short fall | (4.93) | |||
| Skewness | 2.63 | |||
| Kurtosis | 12.64 |
NextCure February 25, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as NextCure stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2,797 | ||
| Daily Balance Of Power | (0.65) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 12.97 | ||
| Day Typical Price | 12.93 | ||
| Price Action Indicator | (0.29) |
Complementary Tools for NextCure Stock analysis
When running NextCure's price analysis, check to measure NextCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCure is operating at the current time. Most of NextCure's value examination focuses on studying past and present price action to predict the probability of NextCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCure's price. Additionally, you may evaluate how the addition of NextCure to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |